This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million.

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.0:00 Introduction 0:53 What is CRISPR?2:05 How Does CRISPR work?3:18 The Experiment5:30 The Results9:31 ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

Our technology can be seen as a breakthrough by resolving the major obstacle linked to the original CRISPR technology, and I am optimistic that in tandem with existing gene scissors, our ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without ...

The University of California and the University of Vienna on Monday convinced a U.S. appeals court to revive their bid for patent rights to groundbreaking CRISPR gene-editing technology created by ...

Stanford researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth – paving the way for potential treatments for neurodegenerative diseases like ...

CRISPR Therapeutics has rallied on Casgevy progress, but overvaluation, early-stage pipeline, and lack of profits raise ...